The latest gynaecological cancer news
A new report highlights the overwhelming economic and societal cost of ovarian cancer in Australia.…
In a randomised clinical trial, researchers from Huntsman Cancer Institute at the University of Utah, USA, (the U)…
A mathematical modeling study conducted in Germany suggests that ovarian cancer incidence could be reduced…
A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients…
It’s a little pill with big responsibilities. But despite its primary role to prevent pregnancy,…
GSK plc announced today that the European Commission has approved dostarlimab in combination with chemotherapy…
Ovarian cancer, a deadly gynecologic malignancy, has seen a significant shift in its treatment paradigm…
A landmark event bringing together health leaders, policymakers, researchers, and advocates from Albania, Bosnia and…
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical…
A recent study led by researchers at the University of Arizona Cancer Center and Northern Arizona…